U.S. market Closed. Opens in 1 hour 34 minutes

MRNA | Moderna, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue6.85B19.26B17.74B274.49M48.04M122.51M176.97M101.54M
Cost of Revenue4.69B5.42B2.62B7.93M31.02M454.08M20.54M15.11M
Gross Profit2.15B13.85B15.12B266.56M17.02M-331.57M156.44M86.42M
Operating Expenses6.39B4.43B1.82B1.03B593.76M535.78M446.33M325.31M
Selling, General & Admin1.55B1.13B567.00M188.27M109.62M94.25M64.72M57.45M
Research & Development4.84B3.29B1.99B1.37B496.31M454.08M410.46M274.72M
Other Operating ExpensesN/A-45.00M-735.00M-528.90MN/A-12.56M-28.85M-2.71M
Operating Income-4.24B9.42B13.30B-763.14M-545.72M-413.27M-269.36M-223.77M
Other Expenses / Income297.00M155.00M-11.00M18.63M31.00M28.86M13.36M8.60M
Before Tax Income-3.94B9.57B13.29B-744.51M-514.72M-384.41M-256.00M-215.17M
Income Tax Expenses772.00M1.21B1.08B2.55M-695.00K326.00K-80.00K1.04M
Net Income-4.71B8.36B12.20B-747.06M-514.02M-384.73M-255.92M-216.21M
Interest Expenses38.00M29.00M18.00M9.89M6.61M3.10M132.00KN/A
Basic Shares Outstanding382.00M394.00M403.00M381.33M330.80M81.11M376.00M376.00M
Diluted Shares Outstanding382.00M416.00M431.00M381.33M330.80M81.11M376.00M376.00M
EBITDA-3.28B9.77B13.53B-732.00M-515.00M-388.40M-235.33M-208.66M
EBITDA Margin-47.94%50.71%76.27%-266.68%-1,072.11%-317.03%-132.97%-205.50%
EBIT-3.90B9.60B13.30B-734.63M-508.10M-381.31M-255.86M-215.17M
EBIT Margin-57.01%49.86%75.01%-267.63%-1,057.76%-311.24%-144.58%-211.91%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙